Microbiological Characteristics, Risk Factors, and Short-Term Mortality of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Pediatric Patients in China: A 10-Year Longitudinal Study
Yujian Liang,Chenfeng Zhao,Yuhang Lu,Kang Liao,Yannan Kong,Mengzhi Hong,Liubing Li,Yili Chen
DOI: https://doi.org/10.2147/idr.s485001
2024-11-03
Infection and Drug Resistance
Abstract:Yujian Liang, 1, &ast Chenfeng Zhao, 2, &ast Yuhang Lu, 3, &ast Kang Liao, 2 Yannan Kong, 4 Mengzhi Hong, 2 Liubing Li, 2 Yili Chen 2 1 Department of Pediatric Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, People's Republic of China; 2 Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, People's Republic of China; 3 Zhongshan Medical School, Sun Yat-sen University, Guangzhou, Guangdong, 510080, People's Republic of China; 4 Department of Laboratory Medicine, the Nanhai's Fifth People's Hospital of Foshan, Foshan, Guangdong, 528231, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yili Chen; Liubing Li, Department of Laboratory Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, People's Republic of China, Email ; Background: Carbapenem-resistant Enterobacteriaceae (CRE) is rapidly becoming a major threat to hospitalized children worldwide. The purpose of this study was to summarize etiological characteristics and identify risk factors relevant to CRE bloodstream infection (BSI) and short-term mortality among pediatric patients in China. Methods: In this study, we included 370 inpatients ≤ 17 years old with BSI caused by Enterobacteriaceae in China from January 2013 to December 2022. By collecting data on demographics, etiological features, and clinical outcomes, we conducted an in-depth analysis. Results: Among the 370 BSI patients with infections caused by Enterobacteriaceae , 35 patients (9.46%) were caused by CRE. Among these CRE strains, Klebsiella pneumoniae (49.46%) was the most important pathogen of BSI in pediatric patients, followed by Escherichia coli (31.62%) and Enterobacter cloacae (5.95%). The most frequent carbapenemase was NDM (23/35, 65.71%), followed by KPC (8/35, 22.86%). The overall 28-day mortality rate of children with an Enterobacteriaceae BSI episode was 1.89% (7/370), of which CRE BSI patients (3/35, 8.57%) were significantly higher than CSE patients (4/335, 1.19%, P < 0.001). Congenital malformation (OR: 8.162, 95% CI: 3.859– 16.680, P < 0.001) and catheter-related (OR: 6.645, 95% CI: 3.159– 13.28, P: < 0.001) were associated with the development of CRE BSI in pediatric patients. A multivariate analysis showed that the infection of CRE (OR 7.758, 95% CI 1.869– 29.62, P = 0.021) were independent risk factors for 28-day mortality of Enterobacteriaceae BSI. When the MIC of any carbapenems was ≥ 8 μg/mL, the mortality rate in the ICU was higher (P < 0.05). Conclusion: Congenital malformation, previous cephalosporin/carbapenems administration, and catheter-related conditions were closely related to the development of CRE BSI. The mortality rate of CRE BSI was higher. NDM was the predominant carbapenemase-producing mechanism in children. Keywords: carbapenem-resistant Enterobacteriaceae , bloodstream infection Carbapenem-resistant Enterobacteriaceae (CRE) is increasingly isolated and poses a great threat to hospitalized children worldwide. 1,2 Oncologic conditions, premature infants, and hospitalization in the intensive care unit (ICU) are frequently reported in available case series of pediatric CRE infections. 3–5 Specifically, bloodstream infections (BSIs) caused by CRE are exceptionally intractable problems in children, with significant morbidity and mortality. 6 Due to the limited treatment options available for children, 7,8 the treatment of CRE BSI is challenging for the pediatrician. The key to successful prevention and treatment of CRE infection is to implement infection control measures and early identification of high-risk patients. Most of the information available on risk factors, clinical characteristics, therapeutic options, and prognosis was provided by adult population studies. It is reported risk factors for CRE-BSI in adults include extended hospital stay, critical illness, medical device intervention, long-term use of broad-spectrum antibiotics, and residency in nursing homes. 9–11 There is still little research information on CRE-BSI in children. 12,13 This study is aimed to summarize the etiological features and determine risk factors for CRE-BSI and predictors of 28-day mortality associated with the infection in a pediatric cohort. Therefore, we conducted a retrospective analysis spanning 10 years. The 10-year time frame enhances the -Abstract Truncated-
pharmacology & pharmacy,infectious diseases